90 related articles for article (PubMed ID: 15063005)
1. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope.
Kanduc D; Fanizzi FP; Lucchese G; Stevanovic S; Sinha AA; Mittelman A
Peptides; 2004 Feb; 25(2):243-50. PubMed ID: 15063005
[TBL] [Abstract][Full Text] [Related]
2. Individuation of monoclonal anti-HPV16 E7 antibody linear peptide epitope by computational biology.
Kanduc D; Lucchese A; Mittelman A
Peptides; 2001 Dec; 22(12):1981-5. PubMed ID: 11786180
[TBL] [Abstract][Full Text] [Related]
3. Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies.
Lidqvist M; Nilsson O; Holmgren J; Hall C; Fermér C
J Immunol Methods; 2008 Sep; 337(2):88-96. PubMed ID: 18606164
[TBL] [Abstract][Full Text] [Related]
4. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity.
Tiwari R; Geliebter J; Lucchese A; Mittelman A; Kanduc D
Peptides; 2004 Nov; 25(11):1865-71. PubMed ID: 15501517
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
6. The molecular specificity of linear B-epitopes in the E7 open reading frame protein of human papillomavirus 16 defined by monoclonal antibodies.
Tindle RW; Zhou WD; Saul A; Frazer IH
Pept Res; 1990; 3(4):162-6. PubMed ID: 1724617
[TBL] [Abstract][Full Text] [Related]
7. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.
Préville X; Ladant D; Timmerman B; Leclerc C
Cancer Res; 2005 Jan; 65(2):641-9. PubMed ID: 15695409
[TBL] [Abstract][Full Text] [Related]
8. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
Grinstead JS; Schuman JT; Campbell AP
Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
[TBL] [Abstract][Full Text] [Related]
9. Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers.
Xu M; Lu X; Sposato M; Zinckgraf JW; Wu S; von Hofe E
Vaccine; 2009 Jul; 27(34):4641-7. PubMed ID: 19520206
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.
Donà MG; Giorgi C; Accardi L
BMC Cancer; 2007 Jan; 7():25. PubMed ID: 17266749
[TBL] [Abstract][Full Text] [Related]
11. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M
J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7(11-20) cytotoxic T lymphocyte epitope.
Schreurs MW; Kueter EW; Scholten KB; Lemonnier FA; Meijer CJ; Hooijberg E
Vaccine; 2005 Jul; 23(31):4005-10. PubMed ID: 15963358
[TBL] [Abstract][Full Text] [Related]
13. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein.
Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY
Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967
[TBL] [Abstract][Full Text] [Related]
14. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
[TBL] [Abstract][Full Text] [Related]
15. Structure, epitope mapping, and docking simulation of a gibberellin mimic peptide as a peptidyl mimotope for a hydrophobic ligand.
Murata T; Hemmi H; Nakamura S; Shimizu K; Suzuki Y; Yamaguchi I
FEBS J; 2005 Oct; 272(19):4938-48. PubMed ID: 16176267
[TBL] [Abstract][Full Text] [Related]
16. Cyclic peptides selected by phage display mimic the natural epitope recognized by a monoclonal anti-colicin A antibody.
Coulon S; Metais JY; Chartier M; Briand JP; Baty D
J Pept Sci; 2004 Nov; 10(11):648-58. PubMed ID: 15568679
[TBL] [Abstract][Full Text] [Related]
17. Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library.
Zhang F; Yu M; Weiland E; Morrissy C; Zhang N; Westbury H; Wang LF
Arch Virol; 2006 Jan; 151(1):37-54. PubMed ID: 16132176
[TBL] [Abstract][Full Text] [Related]
18. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of the phosphorylation motif of the HIV-1 protein Vpu bound to the selective monoclonal antibody using TRNOESY and STD NMR spectroscopy.
Gharbi-Benarous J; Bertho G; Evrard-Todeschi N; Coadou G; Megy S; Delaunay T; Benarous R; Girault JP
Biochemistry; 2004 Nov; 43(46):14555-65. PubMed ID: 15544326
[TBL] [Abstract][Full Text] [Related]
20. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.
Zou P; Liu W; Chen YH
Int Immunopharmacol; 2005 Apr; 5(4):631-5. PubMed ID: 15710332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
